103 related articles for article (PubMed ID: 4208215)
1. [Insulin secretion following combined administration of glucose and different sulfonylurea compounds in equipotential doses in metabolically healthy persons].
Happ J; Beyer J; Jungmann E; Scherer U; Haupt E; Schöffling K
Verh Dtsch Ges Inn Med; 1973; 79():1213-6. PubMed ID: 4208215
[No Abstract] [Full Text] [Related]
2. [Insulin secretion after oral and intravenous administration of various 1st and 2d generation sulfonylurea derivatives in equipotential dosage].
Haupt E; Köberich W; Rosak C; Cordes U; Beyer J; Schöffling K
Verh Dtsch Ges Inn Med; 1972; 78():1272-5. PubMed ID: 4198780
[No Abstract] [Full Text] [Related]
3. Different amounts of insulin secretion following an equal total decrease of blood glucose as an indication of possible extrapancreatic activities of different sulfonylurea drugs.
Beyer J; Haupt E; Cordes U; Kutschera J; Schöffling K
Horm Metab Res; 1973 Jan; 5(1):9-13. PubMed ID: 4196346
[No Abstract] [Full Text] [Related]
4. [Extrapancreatic effects of sulfonylurea compounds. IV. Increase of the effect of insulin due to tolbutamide, glibornuride, and glibenclamide in vitro].
Beyer J; Gather W; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2179. PubMed ID: 4198966
[No Abstract] [Full Text] [Related]
5. [Extrapancreatic effects of sulfonylurea compounds. 3. Studies on the additional blood sugar decreasing and antilipolytic effect of tolbutamide, glibornuride, and glibenclamide on completely pancreatectomized dogs, chronically treated with insulin during acute experiment and following pretreatment with sulfonylurea compounds using small doses of sulfonylurea].
Beyer J; Cordes U; Sell G; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2176. PubMed ID: 4198965
[No Abstract] [Full Text] [Related]
6. [Insulin and pro-insulin secretion following intravenous administration of tolbutamide, glisoxepide and glibenclamide].
Hausmann L; Schumann G; Kaffarnik H
Arzneimittelforschung; 1978; 28(1):83-6. PubMed ID: 415745
[TBL] [Abstract][Full Text] [Related]
7. [Secretion of insulin under the influence of sulfonylurea derivates (SH)].
Rothenbuchner G; Raptis S; Pfeiffer EF
Wien Z Inn Med; 1973; 54(2):69-77. PubMed ID: 4203274
[No Abstract] [Full Text] [Related]
8. Uptake of glibornuride by microdissected pancreatic islets.
Täljedal IB
Horm Res; 1974; 5(4):211-6. PubMed ID: 4210148
[No Abstract] [Full Text] [Related]
9. [Insulin liberation by blood sugar decreasing sulfonamides and by glucose in adult diabetic patients].
Haupt E; Köberich W; Rosak C; Beyer J; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2198. PubMed ID: 4198967
[No Abstract] [Full Text] [Related]
10. Effect of PGE2 on sulfonylurea induced insulin release.
Villar A; Ivorra MD; Anselmi E
J Physiol (Paris); 1987; 82(1):12-7. PubMed ID: 3123643
[TBL] [Abstract][Full Text] [Related]
11. [Comparative use of gliquidone and tolbutamide administered intravenously].
Zilker T; Lüders L; Bottermann P
MMW Munch Med Wochenschr; 1975 Sep; 117(36):1421-2. PubMed ID: 126376
[No Abstract] [Full Text] [Related]
12. [The influence of various sulphonylurea derivatives on the oral glucose-tolerance tests in healthy subjects and obese and maturity-onset diabetics (author's transl)].
Haupt E; Beyer J; Schöffling K
Dtsch Med Wochenschr; 1974 Mar; 99(9):385-8. PubMed ID: 4208186
[No Abstract] [Full Text] [Related]
13. Effects of feeding and fasting on the insulin secretory response to glucose and sulfonylureas in intact rats and isolated perfused rat pancreas.
Bosboom RS; Zweens J; Bouman PR
Diabetologia; 1973 Aug; 9(4):243-50. PubMed ID: 4203349
[No Abstract] [Full Text] [Related]
14. [Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide)].
Loubatières A; Ribes G; Mariani MM; Alric R
Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200420
[No Abstract] [Full Text] [Related]
15. [Studies on the effect of various sulfonylureas during adrenergic blockade of the insulin secretion in man].
Haslbeck M; Brauch K; Hepp KD; Mehnert H
Verh Dtsch Ges Inn Med; 1971; 77():543-6. PubMed ID: 5005529
[No Abstract] [Full Text] [Related]
16. In vitro secretion of insulin after glucose, sulphonylureas, adrenergic and cholinergic substances studied by isolated perfused rat pancreas.
Loubatières A; Loubatières-Mariani MM
Endocrinol Exp; 1974 Jun; 8(2):75-87. PubMed ID: 4209693
[No Abstract] [Full Text] [Related]
17. Biochemical and morphological events associated with the development of fetal rat pancreas "in vivo" and "in vitro": effect of glucagon and of other agents.
Lambert AE; Orci L; Kanazawa Y; Jeanrenaud B; Renold AE
Acta Isot (Padova); 1970; 10(3):191-204. PubMed ID: 4334397
[No Abstract] [Full Text] [Related]
18. Glyburide and tolbutamide induce desensitization of insulin release in rat pancreatic islets by different mechanisms.
Rabuazzo AM; Buscema M; Vinci C; Caltabiano V; Vetri M; Forte F; Vigneri R; Purrello F
Endocrinology; 1992 Oct; 131(4):1815-20. PubMed ID: 1396327
[TBL] [Abstract][Full Text] [Related]
19. [Dose dependance of insulin liberated in early phase following sulfonylurea administration].
Dörfler H; Marshall M; Wolfram G; Zöllner N
Verh Dtsch Ges Inn Med; 1973; 79():1208-10. PubMed ID: 4790140
[No Abstract] [Full Text] [Related]
20. The potentiating effect of the simultaneous administration of tolbutamide, glibenclamide, and gliclazide on the development of alloxan-induced diabetes in rats.
Katsumata K; Katsumata Y
Horm Metab Res; 1990 Jan; 22(1):51-2. PubMed ID: 2106472
[No Abstract] [Full Text] [Related]
[Next] [New Search]
